Objective: To test the hypotheses that an educational program reduces the frequency and severity of urinary tract infections (UTIs) in persons with spinal cord injury (SCI) and impacts health beliefs, locus of control, and self-efficacy.
Design: Randomized controlled study.
Methods: Fifty-six participants were randomized to patient educational program or control groups after a 5- or 6-month baseline period. The educational program group received written material on UTIs, a self-administered test, a review by nurse and physician, and a follow-up telephone call. Data were collected monthly throughout the baseline period and the 5- or 6-month follow-up period.
Outcome Measure: The measures used were significant urine colony counts (UCCs), number of symptoms and UTIs, episodes of antibiotic treatment for UTIs, and 3 questionnaires (the Health Beliefs Questionnaire, the Multidimensional Health Locus of Control [MHLC] Scale, and a self-efficacy questionnaire).
Results: When controlling for baseline counts and the difference between groups at baseline, the treatment group had significantly fewer significant UCCs than did the control group (P = 0.009). A trend also was seen for fewer symptom reports (P = 0.094) and fewer number of antibiotic treatment episodes (P = 0.232) in the treatment group. In addition, whereas the treatment group tended to have higher scores on the internal MHLC Scale (P = 0.066), they also perceived the severity of UTIs as greater than did the control group (P = 0.042) and had lower scores on the self-efficacy questionnaire (P = 0.033).
Conclusion: This is the first randomized controlled trial to demonstrate a significant reduction in bacterial load in the urine of persons with SCIs and an apparent reduction of symptoms and antibiotic treatment episodes for UTIs using a focused educational program. The increased scores on the internal MHLC Scale suggest that individuals in the treatment group felt that they had more control over their health behavior after receiving a UTI educational intervention.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10790268.2004.11753730 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization changes and research waste in randomized controlled trials of global gastroesophageal reflux disease and hiatus hernia over the past 20 years.
Int J Surg
January 2025
Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Background: The results of many large randomized clinical trials (RCTs) have transformed clinical practice in gastroesophageal reflux disease (GERD) and esophageal hiatal hernia (HH). However, research waste (i.e.
View Article and Find Full Text PDFExploration of the Combined Mechanism of Direct and Indirect Effects of Paeoniflorin in the Treatment of Cholestasis.
Inflammation
January 2025
Department of Pharmacy, Chinese PLA General Hospital, Beijing, China.
Cholestasis is a multifactorial hepatobiliary disorder, characterized by obstruction of bile flow and accumulation of bile, which in turn causes damage to liver cells and other tissues. In severe cases, it can result in the development of life-threatening conditions, including cirrhosis and liver cancer. Paeoniflorin (PF) has been demonstrated to possess favourable therapeutic potential for the treatment of cholestasis.
View Article and Find Full Text PDFEffects of lipoic acid on production performance, meat quality, serum biochemistry and antioxidant function in heat-stressed broilers.
Trop Anim Health Prod
January 2025
College of Animal Sciences, Anhui Science and Technology University, Fengyang, 233100, China.
This study was aim to investigate the effects of lipoic acid (ALA) on performance, meat quality, serum biochemistry and antioxidant function of broilers under heat stress (HS). Two hundred1-day-old Cobb broilers were randomly divided into four treatment groups and each treatment consisted of 4 replicates of 10 broilers each. The treatment group adopts a 2 × 2 two-factor setting, which is divided into two diets (basic diet or 250 mg/kg ALA diet) and two temperatures (24 ± 1℃ or 33 ± 1℃).
View Article and Find Full Text PDFEngineering yeast to produce fraxetin from ferulic acid and lignin.
Appl Microbiol Biotechnol
January 2025
Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Lignin, the most abundant renewable source of aromatic compounds on earth, remains underexploited in traditional biorefining. Fraxetin, a naturally occurring flavonoid, has garnered considerable attention in the scientific community due to its diverse and potent biological activities such as antimicrobial, anticancer, antioxidant, anti-inflammatory, and neurological protective actions. To enhance the green and value-added utilization of lignin, Saccharomyces cerevisiae was engineered as a cell factory to transform lignin derivatives to produce fraxetin.
View Article and Find Full Text PDFCharacterization of a novel D-sorbitol dehydrogenase from Faunimonas pinastri A52C2.
Appl Microbiol Biotechnol
January 2025
Key Laboratory of Industrial Biotechnology, Ministry of Education, Jiangnan University, 1800 Lihu Avenue, Wuxi, 214122, China.
The enzyme D-sorbitol dehydrogenase (SLDH) facilitates the conversion of D-sorbitol to L-sorbose. While current knowledge of this enzyme class predominantly centers on Gluconobacter oxydans, the catalytic properties of enzymes from alternative sources, particularly their substrate specificity and coenzyme dependency, remain ambiguous. In this investigation, we conducted BLASTp analysis and screened out a novel SLDH (Fpsldh) from Faunimonas pinastri A52C2.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!